aBeijing Key Laboratory of Cell & Gene Therapy for Solid Tumour, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Early Drug Development Centre, ...

The loss of the Y chromosome in tumour cells is linked to poor outcomes for people with cancer 1, but this genetic alteration might also compromise immune cells that would otherwise fight the disease.

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs. Stem cells (like the ones above, growing in petri dishes) are able to ...

Perovskite solar cells are a high-efficiency, low-cost alternative to traditional silicon-based solar panels. With the perovskite solar cell industry expected to reach $1.2 billion by 2033 ...

Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to shrunken tumors and improved survival, the company announced in ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer (SCLC). The DLL3xCD3 bispecific has shown that it can help patients live ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

Credit: SciTechDaily.com Astrocytes, once thought to be the brain’s housekeepers, may actually be silent powerhouses of memory. MIT scientists have proposed a bold new model where these star-shaped ...

A new sodium–air fuel cell triples lithium battery energy density and could enable electric planes. It’s safer, carbon-negative, and built from cheap, abundant materials — with a startup already ...

CHICAGO, June 1 (Reuters) - A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent glioblastoma, a rare event for a fatal ...

Bispecific T cell engagers (TcEs) are immunotherapeutic drugs that trigger the destruction of cancer cells by linking T cells to cancer cells through specific surface molecules (antigens). We designed ...

Sorting cells with target metabolic functions from a mutant pool exhibiting substantial genetic diversity is often the rate-limiting step in synthetic biology. Here, we developed a label-free, ...